Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Toxins
|
August 26, 2021
Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans
Tarana Arman, John D Clarke
Expert Opinion on Drug Metabolism & Toxicology
|
January 28, 2012
Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions
John D Clarke, Nathan J Cherrington
Pharmacology & Therapeutics
|
March 26, 2015
Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability
John D Clarke, Nathan J Cherrington
Drug Metabolism Reviews
|
July 30, 2024
Mechanisms of intestinal pharmacokinetic natural product-drug interactions
Victoria O Oyanna, John D Clarke
Cancer Letters
|
May 28, 2008
Multi-targeted prevention of cancer by sulforaphane
John D Clarke, Roderick H Dashwood, Emily Ho
The Journal of Nutrition
|
October 9, 2009
Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention
Emily Ho, John D Clarke, Roderick H Dashwood
Chemosphere
|
November 4, 2020
Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol diet
Tarana Arman, Katherine D Lynch, Michael Goedken, et al.
Molecular Nutrition & Food Research
|
March 5, 2011
Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells
John D Clarke, Anna Hsu, Zhen Yu, et al.
Biochemical Pharmacology
|
December 28, 2019
Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance
Erica L Toth, John D Clarke, Iván L Csanaky, et al.
Toxins
|
July 21, 2019
Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats
Tarana Arman, Katherine D Lynch, Michelle L Montonye, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Toxins
|
August 26, 2021
Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans
Tarana Arman, John D Clarke
Expert Opinion on Drug Metabolism & Toxicology
|
January 28, 2012
Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions
John D Clarke, Nathan J Cherrington
Pharmacology & Therapeutics
|
March 26, 2015
Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability
John D Clarke, Nathan J Cherrington
Drug Metabolism Reviews
|
July 30, 2024
Mechanisms of intestinal pharmacokinetic natural product-drug interactions
Victoria O Oyanna, John D Clarke
Cancer Letters
|
May 28, 2008
Multi-targeted prevention of cancer by sulforaphane
John D Clarke, Roderick H Dashwood, Emily Ho
The Journal of Nutrition
|
October 9, 2009
Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention
Emily Ho, John D Clarke, Roderick H Dashwood
Chemosphere
|
November 4, 2020
Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol diet
Tarana Arman, Katherine D Lynch, Michael Goedken, et al.
Molecular Nutrition & Food Research
|
March 5, 2011
Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells
John D Clarke, Anna Hsu, Zhen Yu, et al.
Biochemical Pharmacology
|
December 28, 2019
Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance
Erica L Toth, John D Clarke, Iván L Csanaky, et al.
Toxins
|
July 21, 2019
Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats
Tarana Arman, Katherine D Lynch, Michelle L Montonye, et al.
Page
of 6